Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)
Kestra Medical Technologies (KMTS) posted quarterly Preferred Stock Liabilities of $280.5 million for Q1 2025, up 58.38% quarter-over-quarter from $177.1 million in Q2 2024.
Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Preferred Stock Liabilities for 2 consecutive years, with $280.5 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Preferred Stock Liabilities changed N/A year-over-year to $280.5 million; the TTM figure through Jan 2025 stood at $280.5 million (changed N/A YoY), while the FY2024 annual figure was $177.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities climbed to $280.5 million in Q1 2025 per KMTS's latest filing, from $177.1 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $280.5 million in Q1 2025 and bottomed at $177.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 280.51 Mn |
| Apr 30, 2024 | 177.11 Mn |